Second Funding Period of the TRR259 “Aortic Disease” Approved

IMMEI contributes with a project elucidating inflammatory immune mechanisms and the role of the microbiome in the development of aortic valve stenosis.

The Transregional Collaborative Research Centre 259 “Aortic Diseases” has been approved by the DFG for a second funding period (2023-2027). Within the consortium basic and clinical researchers of the Universities of Bonn, Cologne and Düsseldorf are working together to expand the incomplete understanding of fundamental principles in the genesis and development of aortic diseases.
From our institute, Prof Christian Kurts and Maria Belen Rodrigo are part of the TRR259. Together with PD Dr Christina Weisheit from the Clinic for Anesthesiology and Surgical Intensive Care medicine, they address inflammatory immune mechanisms and the role of the microbiome in the development of aortic valve stenosis with the long-term goal of identifying novel pathogenic players as potential targets for future therapies.

For more details visit the TRR259 website or read the UKB press release.